PharmiWeb.com - Global Pharma News & Resources

Conference - Events

Featured Events

Events

Kick off 2026 and set the tone for the year at 18th Annual Pre-Filled Syringes and Injectable Drug Devices Conference! Join us in London on the 13th - 15th January 2026 where we will unite leaders and innovators from the device development industry. This highly anticipated conference offers unparalleled opportunities to explore the latest advances in combination product technology, share insights, and foster collaboration across a dynamic three-day program. As part of SAE's leading Injectable Drug Delivery Series, the event features: - Pre-Conference Focus Day: PFS Design for Enhanced Drug Delivery- Two-Day Main Conference: Morning keynote plenaries and afternoon parallel topic streams addressing the industry's most pressing challenges, including:- Large-Volume Drug Delivery Solutions- Sus…
PFS and Injectable Drug Devices Europe 2026
The Pharma and Biotech Patent Litigation Track at the Patent Litigation Europe Summit 2026 is the leading European forum for life sciences IP counsel and litigators to benchmark enforcement strategies, navigate evolving UPC case law, and prepare for the next wave of biosimilar and generic challenges. Taking place on 20–21 January 2026 at the Beurs van Berlage in Amsterdam, the track continues the legacy of the Pharma and Biotech Patent Litigation Summit while introducing a broader cross-sector environment under the newly rebranded Patent Litigation Europe umbrella. This stream remains the anchor event for the life sciences audience, attracting around 600 attendees, with an exceptional 45% in-house counsel ratio from leading pharmaceutical innovators, biotechs, generics and biosimilar devel…
The Pharma and Biotech Patent Litigation Conference
Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle. From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma. Key Topics Include:  Transformative portfolio management approaches using AI Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution Bridging the Gap Between Market Objectives and Research Needs Achieving a strategic…
29th Edition Strategic Project & Portfolio Management for Pharma
Attend the Marcus Evans 29th Edition Strategic Project & Portfolio Management for Pharma conference taking place in Frankfurt, Germany between 26-28 January and join industry leaders, strategists, and innovators for an exclusive event focused on transforming how portfolios are prioritized, managed, and accelerated across the R&D lifecycle. From strategic portfolio planning and dynamic resource allocation to AI-powered decision support and cross-functional execution, discover the latest approaches driving agility and impact in pharma. Key Topics Include:  Transformative portfolio management approaches using AI Strategic Agility in the Age of AI: Leading Pharma Portfolio from Vision to Execution Bridging the Gap Between Market Objectives and Research Needs Achieving a strategic…
29th Edition Strategic Project & Portfolio Management for Pharma
27-Jan-2026 - 29-Jan-2026
Discover, Develop and Selectively Deliver Highly Stable and Potent RNAi Therapeutics for Targeted and Effective Gene Silencing in Oncology, Rare, Cardiovascular Disorders and Beyond The 7th RNAi-Based Therapeutics Summit is the industry's premier dedicated forum for translating the next wave of siRNA and microRNA drugs from bench to bedside. As the only event uniting the entire RNAi ecosystem from discovery and complex chemistry to clinical development and CMC, this Summit provides an unparalleled platform to tackle the field's most pressing challenge: delivery beyond the liver. This is your unique opportunity to join 80+ senior leaders from pharma and biotech to gain the data-driven insights and high-value connections needed to overcome stability challenges, de-risk clinical translation,…
7th RNAi-Based Therapeutics Summit
mRNA is no longer just a headline, it's transforming medicine. From BioNTech's acquisition of CureVac to the EMA's and MHRA's latest guidance on mRNA product development, and even the world's first personalised CRISPR therapy for Baby KJ, the field has reached a new level of stability while opening doors to revolutionary therapeutic and gene editing applications. Returning for its fifth year, the mRNA-Based Therapeutics Summit Europe gives you the insights and connections to turn these breakthroughs into action. The new Gene Editing Focus Day highlights how mRNA enables safer, transient editing strategies, while addressing regulatory and translational challenges. Hear directly from Moderna, AstraZeneca, CybernaX Bio, Avocet Bio, and others about clinical readiness and delivery innovations…
5th mRNA-Based Therapeutics Summit Europe
Enabling Rapid Target Selection, Discovery and Rational Design of Degrading and Non-Degrading Molecular Glue to Develop Potent, Selective and Safer Cures for Cancer and Beyond. Molecular glues are leading the charge in the race to drug the previously undruggable, and 2025 has seen continued investment and partnerships driving innovation in this field. Returning as the industry’s only dedicated meeting, the 4th Molecular Glue Drug Development Summit brings top experts from biopharma and academia together for intimate networking and scientific content sharing. Designed to address the unique challenges of molecular glues, this meeting will provide actionable strategies to accelerate the development of safer, more selective candidates toward the clinic. If you’re looking to lead the way in the…
4th Molecular Glue Drug Development Summit | Boston, MA | January 27-29, 2026
27-Jan-2026 - 29-Jan-2026
Returning to Boston for its 9th year, the DDR Inhibitors Summit is the definitive industry forum for drug developers advancing DNA Damage Response (DDR)-targeted therapies. With PARP inhibitors now clinically validated, the field is rapidly evolving to explore novel DDR targets like ATR, CHK1/2, DNA-PK, and WEE1, alongside smarter biomarker strategies and combination approaches. This year's summit is your opportunity to stay ahead of the curve. Across three content-rich days, you'll uncover translational breakthroughs, hear from biotech innovators and academic pioneers, and gain strategic insights to overcome resistance, enhance selectivity, and accelerate clinical success. With the DDR landscape rapidly expanding, now is the time to connect, collaborate, and shape the future of targeted o…
9th DDR Inhibitors Summit
27-Jan-2026 - 29-Jan-2026
For more than two decades, biopharma has struggled to develop safe and effective non-opioid pain therapies. With Vertex’s recent approval marking a long-awaited breakthrough, the momentum has reached a critical point for bringing non-opioid pain therapeutics to market. Whether advancing NaV-targeting drugs or pursuing novel pain mechanisms, non-opioid therapeutics are now in the clinical spotlight and the next 12 months promise to be transformative. The Non-Opioid Pain Therapeutics Summit provides a dedicated platform to harness that momentum. Attendees will be learning from companies with approvals such as Tonix, exploring late-stage strategies from innovators like Latigo and Algiax, and uncovering discovery breakthroughs from Nocion and Axonis. Join 70+ discovery, preclinical, translatio…
Non-Opioid Pain Therapeutics Summit
27-Jan-2026 - 28-Jan-2026
Inspection Readiness 360 unites clinical operations, TMF, quality, and regulatory leaders for two days of expert insights, case studies, and strategies to ensure your organization is inspection-ready in any environment. Date and Time: On Tue, 27 Jan 2026 09:00 - Wed, 28 Jan 2026 17:00 Venue Details: Convene Two Commerce Square, 2001 Market Street, Philadelphia, Pennsylvania, 19103, United States Category: Conferences | Science, Health and Medicine
Inspection Readiness 360
27-Jan-2026 - 28-Jan-2026
Discover how AI is transforming medical affairs at the 5th Annual AI in Medical Affairs, taking place January 27-28, 2026, in Philadelphia, PA.Join pharmaceutical, biotech, and medical device leaders to explore real-world AI applications, innovative strategies, and compliance best practices.Engage in expert panels, case studies, and networking to gain actionable insights that enhance content creation, optimize field medical operations, and drive impactful stakeholder engagement. Time: 9:00 AM - 5:00 PM Venue Details: Convene Two Commerce Square, 2001 Market Street, Philadelphia, Pennsylvania, 19103, United States Category: Conferences | Science, Health and Medicine
5th Annual AI in Medical Affairs
Europe's leading digital pharma event is back. The 14th Annual Digital Pharma Advances Conference returns to the Grand Connaught Rooms, London, uniting 35+ senior executives from 13 of the world's top 20 pharmaceutical companies — including AstraZeneca, Pfizer, Novartis, Novo Nordisk, GSK, Teva, Bayer, and Roche — to explore practical AI applications, omnichannel marketing strategies, HCP engagement, and patient-centric approaches. Key Themes: AI and digital innovation in pharma Omnichannel marketing strategies HCP engagement and digital experience Patient-centric and personalised approaches Actionable insights from top pharma leaders Who Should Attend:Pharma marketing, digital, commercial, brand, patient engagement, innovation, and transformation leaders seeking prac…
14th Annual Digital Pharma Advances Conference
The 10th Liquid Biopsy for Precision Oncology Summit is the leading annual meeting for pharma, biotech, diagnostics, consortia, academia and patient voices to accelerate collaboration and progress in the rapidly advancing field of liquid biopsy.  Now in its 10th year, this meeting delivers unparalleled insights, data, technology updates, and strategies spanning the entire drug development pipeline - from preclinical discovery, through clinical translation, to regulatory approval, reimbursement, and commercial adoption.  If you are working in precision oncology, or need enhanced insights into your patient population, optimized diagnostic and prognostic tools, or earlier detection of disease, this meeting should be considered a staple entry in your conference calendar. Across ctDNA…
10th Liquid Biopsy for Precision Oncology Summit | February 3-5, 2026 | Free* for Biopharma
The approval of the first anti-amyloid drugs has resurrected the neurodegenerative disease space, opening the door for enhanced competition and innovation to develop novel disease-modifying therapies. However, as challenges remain in the clinical adoption of Lecanemab and Donanemab, the field needs to navigate the move towards disease-modifying therapeutics. Capitalizing on the surge of innovation across new targets, lessons learned from clinical setbacks, groundbreaking progress in blood-based diagnostics, and more, the 14th Alzheimer’s and Parkinson’s Drug Development Summit returns as the only industry-focused and end-to-end meeting, with comprehensive coverage spanning early discovery through to late clinical and regulatory.   URLs:Tickets: https://go.evvnt.com/3259347-2?pid=185&n…
14th Alzheimer's and Parkinson's Drug Development Summit
With Novartis committing $750M to ProFound Therapeutics to discover new cardiovascular candidates, and Illumina acquiring SomaLogic for $425 to expand its proteomic capabilities just this year alone, the increasing recognition of proteomics as a transformative force in drug discovery is unquestionable. Returning to Boston for its second year, the Proteomics-Based Drug Discovery Summit is the premier industry event dedicated to harnessing the full power of proteomics across drug discovery pipelines. Designed for scientific innovators like you, explore how next-generation proteomic platforms are accelerating understanding of pathology, unveiling novel drug targets, and transforming hit-to-lead development. With a special focus on optimizing proteomics instruments to balance throughput and se…
2nd Proteomic Based Drug Discovery Summit 2026
Join us at the forefront of innovation at the Marcus Evans 15th Edition R&D and Innovation Excellence Forum, where industry leaders will explore the latest strategies to optimise investments, streamline decision-making, and accelerate transformation in R&D and Innovation. Dive into practical insights on balancing portfolios, maximising ROI, and aligning innovation with market demands. This event is your gateway to understanding how to drive efficiency, foster cross-functional collaboration, and refine R&D and Innovation processes to stay ahead in an increasingly competitive landscape. Don't miss out on this opportunity to empower your R&D team with the tools and knowledge to thrive in a rapidly evolving market. Key Topics Include:  Achieving Operational Excellence in…
15th Edition R&D and Innovation Excellence Forum
The Pharma Market Research Conference East (February 4-5, 2026, New Jersey) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 15+ years. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives. The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships. Attendees will walk away with invaluable information, integrated connections, and countless business opportunities. For more information, please go to http://pharmamarketresearchconference.com/ , call +1-212-228-7974, or email info@pharmamarketresearchconference.com